Study Looks at Illness Trajectories After Revascularization in Patients With PAD

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, July 22, 2024 -- For patients undergoing lower limb revascularization for peripheral artery disease (PAD), the amputation rate is higher for nonelective patients, as is the mortality rate at five years after revascularization, according to a study published in the July 23 issue of Circulation.

Qiuju Li, Ph.D., from the London School of Hygiene and Tropical Medicine, and colleagues analyzed 94,690 patients (≥50 years) undergoing limb revascularization for PAD from 2013 to 2020 to examine the illness trajectories.

The researchers found that 34.8 percent of patients had nonelective revascularization and the others had elective procedures. The amputation rate was 15.2 and 19.9 percent at one and five years, respectively, after revascularization for nonelective patients. The corresponding amputation rates were 2.7 and 5.3 percent for elective patients. Patients who were younger, had tissue loss, diabetes, greater frailty, nonelective revascularization, and more distal procedures had higher risk of major amputation. At five years after revascularization, the mortality rate was 64.3 and 33.0 percent for nonelective and elective patients, respectively. Patients were at increased risk of mortality if they underwent major amputation within six months after index revascularization.

"People with severe forms of PAD requiring urgent surgery tend to have extremely poor disease progress," Li said in a statement. "They are at high risk of limb loss and all-cause death following the initial surgery."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-23 03:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords